Data Integrity & Digital Pharma Operations – Page 18

Missing chain-of-custody links in LIMS result entry and review: Data Integrity Risks and Corrective Controls

The initial detection of LIMS data integrity issues often occurs through various signals on the manufacturing floor or within laboratory environments. Some common symptoms include:Click to read the full article.

Why Unreviewed Failed Runs Happens and How QA Teams Should Control It

Unreviewed failed runs can present themselves through various symptoms that may indicate underlying issues in the analytical process. Key signals to watch for include:Click to read the full article.

How to Defend Manual Data Entries During Regulatory Inspections

Strategies for Ensuring Data Integrity During Regulatory Inspections In a recent inspection at a mid-sized pharmaceutical manufacturer, the regulatory agency raised concerns about the integrity of manually entered data throughout…

Missing chain-of-custody links in LIMS stability sample pulls: Data Integrity Risks and Corrective Controls

Understanding the root causes of missing chain-of-custody links involves examining multiple categories. Below are the most common causes grouped by category:Click to read the full article.

Step-by-Step Guide to Managing Sample Set Modification Under ALCOA+ Expectations

Identifying early signals that suggest potential data integrity issues is crucial for preventing deviations that could impact both product quality and compliance. Some common indications include:Click to read the full…

Data Integrity During Inspections: SOPs, Evidence, and Interview Preparation

During inspections, several symptoms may indicate potential data integrity issues. Common signals include:Click to read the full article.

Delayed sample status updates in LIMS sample login and accessioning: Data Integrity Risks and Corrective Controls

Identifying symptoms early is crucial to mitigating the risks associated with delayed sample status updates. Common signals that may indicate underlying LIMS data integrity issues include:Click to read the full…

How to Prevent CDS Backup and Restore Gaps in CDS (Chromatography Data System) Risks

Early detection of CDS data integrity issues is pivotal for maintaining compliance and operational efficiency. Common symptoms of backup and restore gaps include:Click to read the full article.

How to Prepare LIMS Records for FDA Data Integrity Inspection

Identifying symptoms of LIMS data integrity issues is crucial for timely corrective actions. Common signals that may indicate compromises in data integrity during inspections include:Click to read the full article.

Delayed sample status updates in LIMS test assignment workflows: Data Integrity Risks and Corrective Controls

Best Practices for Addressing Delayed Sample Status Updates in LIMS Workflows The pharmaceutical industry increasingly relies on laboratory information management systems (LIMS) to maintain robust data integrity throughout the sample…

Time Synchronization Failures: Root Causes, GMP Risks, and CAPA Controls

Identifying symptoms early is crucial for mitigating the impact of time synchronization failures. Common indicators that signify potential failures in your chromatography data systems include:Click to read the full article.

Inspector Questions on Metadata: How Pharma Teams Should Respond

Identifying issues with data integrity often begins with observing blatant signals on the shop floor or in the lab. These can manifest as inconsistent results or discrepancies in metadata documentation.…